EFFICACY OF ETANERCEPT TREATMENT AS A SECOND TNF α INHIBITOR IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS AND PRIMARY AND SECONDARY INEFFICIENCY OR INTOLERANCE OF INFLIXIMAB

• Main Authors: E. I. Alexeeva (Author), T. M. Bzarova (Author), A. N. Fetisova (Author), T. V. Sleptsova (Author), K. B. Isaeva (Author), S. I. Valieva (Author), R. V. Denisova (Author), E. V. Mitenko (Author), E. G. Chistyakova (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2012-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The aim of the study was to assess the efficacy and safety of etanercept treatment in combination with methotrexate in 32 patients with juvenile idiopathic arthritis and primary and secondary inefficiency of intolerance of infliximab. In 1 month after the switching to etanercept the improvement was...